Antiflower for Systemic Use Xi. - Isavuconazole

CzechTenders notice for Antiflower for Systemic Use Xi. - Isavuconazole. The reference ID of the tender is 114253962 and it is closing on 10 Mar 2025.

100% Secure Payments

Tender Details

  • Country: Czech Republic
  • Summary: Antiflower for Systemic Use Xi. - Isavuconazole
  • CZT Ref No: 114253962
  • Deadline: 10 Mar 2025
  • Competition: ICB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: 8126000
  • Notice Type: Tender
  • Document Ref. No.: 79982-2025
  • Purchaser's Detail :
  • Purchaser : INSTITUTE OF CLINICAL AND EXPERIMENTAL MEDICINE
    Address: Vienna 1958
    Town: Prague
    NUTS-CODE: CZ010
    Postal Code: 14000
    Phone: +420 261365064
    Email :monika.siskova@ikem.cz
    URL :https://www.ikem.cz

  • Description :
  • The subject of the public contract is the supply of medicinal products for oral and parenteral administrations containing the active substance isavuconazole (ATC group J02AC05) for the treatment of outpatient and hospitalized patients in approved indications according to SPC valid on the date of submission.
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
CzechTenders Features

CzechTenders Features

Fresh and verified Tenders from Czech. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Czech in your email inbox.

  Chat with us